1don MSN
Measurement of nuclear reactions at record-low energies opens new pathways for astrophysics research
An international research team has achieved an important milestone for astrophysics at GSI/FAIR in Darmstadt: In the ...
A tiny object half a universe away, a scar in a stream of stars circling the Milky Way, and an unusual star cluster in a ...
Maine just became the first state to pass a ban on large data centers, sending a strong signal that many communities aren’t ...
Morning Overview on MSN
Megawatt light array generates 3,070 phase-coherent optical vortices
In a lab at Osaka University, physicist Yoshiki Nakata and his colleagues fired a pulsed laser through a stack of three passive optical components and watched it shatter into 3,070 tiny, spinning ...
Optimized Electrotech builds AI-powered electro-optical systems for defence, backed by Rs 100 crore and deployed with Indian ...
India Today on MSN
Harvard student makes tool that uses AI to crack down on AI text and make it look human
A Harvard Business School student has created an anti-Grammarly tool that uses AI to add mistakes to text. It comes at a time ...
Trains on MSN
How G&W's transloading network and industrial development teams are helping to reshape regional supply chains
When King Milling announced a $42 million expansion at its Lowell, Michigan, facility, including a fourth flour mill, the state’s largest flour producer needed a railroad that could keep up. Grand ...
Researchers at KRISS observed water’s rapid freeze–melt cycles under ultrahigh pressure and discovered Ice XXI, the first new ice phase found in decades. Using advanced high-pressure tech and ...
SpaceX would be sixth-largest US-listed firm at IPO valuation Starlink underpins majority of SpaceX's revenue Debate centers on which publicly traded firms are truly comparable, if any April 8 ...
This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...
Altimmune has announced it expects to produce topline data from its phase 2 RECLAIM study of pemvidutide in alcohol use disorder. ALT is planning to start a large phase 3 of pemvidutide in MASH in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results